398 related articles for article (PubMed ID: 1321639)
1. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation.
Feoktistov IA; Paul S; Hollister AS; Robertson D; Biaggioni I
Am J Hypertens; 1992 Jun; 5(6 Pt 2):147S-153S. PubMed ID: 1321639
[TBL] [Abstract][Full Text] [Related]
2. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
Paul S; Feoktistov I; Hollister AS; Robertson D; Biaggioni I
Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405
[TBL] [Abstract][Full Text] [Related]
3. High molecular weight kininogen inhibits thrombin-induced platelet aggregation and cleavage of aggregin by inhibiting binding of thrombin to platelets.
Puri RN; Zhou F; Hu CJ; Colman RF; Colman RW
Blood; 1991 Feb; 77(3):500-7. PubMed ID: 1846761
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of action of adenosine on intracellular calcium and platelet aggregation].
Feoktistov IA; Pol S; Khollister AS; Robertson D; Biadzhoni I
Kardiologiia; 1991 Nov; 31(11):76-9. PubMed ID: 1666665
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
6. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect.
Rao AK; Willis J; Kowalska MA; Wachtfogel YT; Colman RW
Blood; 1988 Feb; 71(2):494-501. PubMed ID: 2827817
[TBL] [Abstract][Full Text] [Related]
7. Effects of dihydropyridines and inorganic calcium blockers on aggregation and on intracellular free calcium in platelets.
Palés J; Palacios-Araus L; López A; Gual A
Biochim Biophys Acta; 1991 May; 1064(2):169-74. PubMed ID: 1645196
[TBL] [Abstract][Full Text] [Related]
8. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
9. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
Vuorinen P; Laustiola KE
Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.
Droller MJ; Wolfe SM
J Clin Invest; 1972 Dec; 51(12):3094-103. PubMed ID: 4344994
[TBL] [Abstract][Full Text] [Related]
11. Direct inhibitory mechanisms of halothane on human platelet aggregation.
Kohro S; Yamakage M
Anesthesiology; 1996 Jul; 85(1):96-106; discussion 30A. PubMed ID: 8694388
[TBL] [Abstract][Full Text] [Related]
12. Studies on antiplatelet effects of OP-41483, a prostaglandin I2 analog, in experimental animals. II. Mechanism of its antiplatelet effect.
Fujitani B; Wakitani K
Jpn J Pharmacol; 1990 May; 53(1):25-33. PubMed ID: 2161965
[TBL] [Abstract][Full Text] [Related]
13. Toborinone and olprinone, phosphodiesterase III inhibitors, inhibit human platelet aggregation due to the inhibition of both calcium release from intracellular stores and calcium entry.
Kageyama K; Mizobe T; Nozuchi S; Hiramatsu N; Nakajima Y; Aoki H
J Anesth; 2004; 18(2):107-12. PubMed ID: 15127258
[TBL] [Abstract][Full Text] [Related]
14. Removal of extraplatelet Na+ eliminates indomethacin-sensitive secretion from human platelets stimulated by epinephrine, ADP, and thrombin.
Connolly TM; Limbird LE
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5320-4. PubMed ID: 6577431
[TBL] [Abstract][Full Text] [Related]
15. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
[TBL] [Abstract][Full Text] [Related]
17. Human platelet secretion and aggregation induced by calcium ionophores. Inhibition by PGE1 and dibutyryl cyclic AMP.
Feinstein MB; Fraser C
J Gen Physiol; 1975 Nov; 66(5):561-81. PubMed ID: 172596
[TBL] [Abstract][Full Text] [Related]
18. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
[TBL] [Abstract][Full Text] [Related]
19. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
[TBL] [Abstract][Full Text] [Related]
20. Effects of anagrelide on platelet cAMP levels, cAMP-dependent protein kinase and thrombin-induced Ca++ fluxes.
Seiler S; Arnold AJ; Grove RI; Fifer CA; Keely SL; Stanton HC
J Pharmacol Exp Ther; 1987 Nov; 243(2):767-74. PubMed ID: 2824759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
